AzTrials
AzTrials

Increased Intracranial Pressure DisordersNCT07162922

Optic Nerve Sheath Diameter Changes in Laparoscopic Cholecystectomy

A study testing 8 mmHg pressure group and 14 mmHg pressure group in people with Increased Intracranial Pressure Disorders and Perioperative Complication, run by Engin Çetin at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose The goal of this clinical trial is to learn how different intra-abdominal pressures during laparoscopic cholecystectomy affect the optic nerve sheath diameter (ONSD), which is a non-invasive marker of intracranial pressure. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
8 mmHg pressure group and 14 mmHg pressure group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteTurkey (Türkiye)
Study dates
17 Sep 2025to 21 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18-65 years of age
  • ASA physical status I-II
  • BMI < 30 kg/m²
  • Scheduled for elective laparoscopic cholecystectomy

Who cannot join

  • Known neurological diseases
  • Ocular pathology
  • History of elevated intracranial pressure (ICP)
  • Pregnancy
  • Need for emergency surgery

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • University of Health Sciences Kocaeli City Hospital

    Kocaeli, Izmit, 41100

Other trials in Turkey (Türkiye)

About this study

Official title: Impact of Intra-abdominal Pressure on Optic Nerve Sheath Diameter During Laparoscopic Cholecystectomy: A Randomized Prospective Study

Purpose The goal of this clinical trial is to learn how different intra-abdominal pressures during laparoscopic cholecystectomy affect the optic nerve sheath diameter (ONSD), which is a non-invasive marker of intracranial pressure. The study will also evaluate whether these changes are related to symptoms such as headache, confusion, and nausea after surgery.

Study Design

Read more

This is a prospective, randomized, double-blind clinical trial. Patients undergoing elective laparoscopic cholecystectomy will be assigned to one of two groups:

Group 1: pneumoperitoneum at 8 mmHg Group 2: pneumoperitoneum at 14 mmHg ONSD will be measured at several time points before, during, and after surgery using transorbital ultrasonography.

Read the detailed description

Purpose The aim of this clinical trial is to investigate how different intra-abdominal pressures applied during laparoscopic cholecystectomy affect the optic nerve sheath diameter (ONSD), which serves as a reliable, non-invasive marker of intracranial pressure. The study also seeks to determine whether perioperative ONSD changes are associated with postoperative symptoms such as headache, nausea, and disorientation, as well as with recovery parameters and hemodynamic stability.

Study Design

This is a prospective, randomized, double-blind, interventional clinical trial. Eligible patients scheduled for elective laparoscopic cholecystectomy will be randomized into two groups based on pneumoperitoneum pressure:

Group 1 (Low-pressure group): pneumoperitoneum maintained at 8 mmHg Group 2 (High-pressure group): pneumoperitoneum maintained at 14 mmHg

ONSD will be measured via transorbital ultrasonography at standardized perioperative time points:

T0: Before induction of anesthesia

T1: 30 minutes after initiation of pneumoperitoneum

T2: 5 minutes after extubation

T3: 1 hour postoperatively

T4: 2 hours postoperatively

All ultrasonographic assessments will be performed by a trained investigator blinded to the patient's group allocation.

Participation Patients will receive anesthesia and undergo laparoscopic cholecystectomy according to standard surgical protocols.

Each participant will be randomly assigned to one of the two pneumoperitoneum pressure groups (8 mmHg or 14 mmHg).

After surgery, patients will be observed in the recovery unit. Postoperative symptoms including headache, nausea and vomiting will be recorded.

Being tested
8 mmHg pressure group, 14 mmHg pressure group
Keywords
optic nerve sheath,, ultrasonography,, cholesistectomy,, pneumoperitoneum
Medical subject headings
Pneumoperitoneum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 8 mmHg pressure groupOther

    Laparoscopic cholecystectomy will be performed with intra-abdominal pressure maintained at 8 mmHg during insufflation. Standard anesthesia and surgical protocols will be followed.

  • 14 mmHg pressure groupOther

    Laparoscopic cholecystectomy will be performed with intra-abdominal pressure maintained at 14 mmHg during insufflation. Standard anesthesia and surgical protocols will be followed.

Study groups in NCT07162922
Study groupRoleWhat they receive
8 mmHg pressure groupActive comparatorPatients in this group will undergo laparoscopic cholecystectomy with pneumoperitoneum maintained at 8 mmHg.
Receives: Other: 8 mmHg pressure group
14 mmHg pressure groupActive comparatorPatients in this group will undergo laparoscopic cholecystectomy with pneumoperitoneum maintained at 14 mmHg.
Receives: Other: 14 mmHg pressure group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effects of Pneumoperitoneum Pressure on ONSD Over Time

    To compare the effect of two different pneumoperitoneum pressures (8 mmHg vs. 14 mmHg) on optic nerve sheath diameter (ONSD) during laparoscopic cholecystectomy. ONSD will be assessed by measuring changes with transorbital ultrasonography at multiple perioperative time points

    Measured: T0: Before intubation T1: 30 minutes after the initiation of pneumoperitoneum T2: 5 minutes after extubation T3: 1 hour after extubation T4: 2 hours after extubation

Secondary outcomes (3)
  1. Number of participants with postoperative nausea assessed by a standardized 4-point nausea scale

    Postoperative nausea will be assessed one hour after surgery using a standardized 4-point scale (0 = no nausea, 1 = mild, 2 = moderate, 3 = severe). The number and proportion of participants with any nausea (score ≥1) will be recorded. Higher scores indicate worse symptoms.

    Measured: One hour after surgery

  2. Number of participants with postoperative vomiting within one hour after surgery

    Occurrence of vomiting will be recorded during the first postoperative hour. The number and percentage of participants experiencing at least one vomiting episode will be documented (yes/no outcome)

    Measured: One hour after surgery

  3. Severity of postoperative headache assessed by Numerical Rating Scale (NRS, 0-10)

    Postoperative headache will be evaluated one hour after surgery using a Numerical Rating Scale (NRS), where 0 = no pain and 10 = worst possible pain. Mean NRS scores and the proportion of participants with moderate-to-severe headache (NRS ≥4) will be reported. Higher scores indicate more severe pain.

    Measured: One hour after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2025
  2. Study start17 Sep 2025
  3. Primary completion21 Dec 2025
  4. Study completion21 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel Assignment
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07162922
Sponsor's protocol ID
KSH-ANREA-EC-02
Status last verified
Dec 2025
First submitted
20 Aug 2025
Last updated
29 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Blecha S, Harth M, Schlachetzki F, Zeman F, Blecha C, Flora P, Burger M, Denzinger S, Graf BM, Helbig H, Pawlik MT. Changes in intraocular pressure and optic nerve sheath diameter in patients undergoing robotic-assisted laparoscopic prostatectomy in steep 45 degrees Trendelenburg position. BMC Anesthesiol. 2017 Mar 11;17(1):40. doi: 10.1186/s12871-017-0333-3.

    PubMed 28284189
  • Cetin E, Gunel B, Yilmaz M, Ergun A. Dynamic effects of low- and high-pressure pneumoperitoneum on optic nerve sheath diameter during laparoscopic cholecystectomy: a prospective, randomized, observer-blinded clinical trial. BMC Anesthesiol. 2026 Mar 19;26(1):266. doi: 10.1186/s12871-026-03762-7.

    PubMed 41851846

Questions about this trial

What is this clinical trial studying?

A study testing 8 mmHg pressure group and 14 mmHg pressure group in people with Increased Intracranial Pressure Disorders and Perioperative Complication, run by Engin Çetin at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effects of Pneumoperitoneum Pressure on ONSD Over Time (time frame: T0: Before intubation T1: 30 minutes after the initiation of pneumoperitoneum T2: 5 minutes after extubation T3: 1 hour after extubation T4: 2 hours after extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07162922, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in